Peptídeos de fornecimento CJC1295 sem DAC CJC1-295 Prime

1. What is CJC 1-2'9-5

CJC 1-2'9-5 is an injectable peptide used to increase GH production. This peptide is a hor-mo-ne releasing hor-m-one (GHRH) mimetic, or analog. That is to say, it works in the same way as GH-RH, and may be referred to as being a GHRH.
The principal use of CJC-1-2'9-5 is to provide increased GH levels, which also results in increased I-'GF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including CJC-1-2'9-5, is chosen as an alternate to using GH, and only rarely is combined with GH.
The other principal GHRH product is Mod GRF 1-29, which in most instances I recommend over CJC-1-2'9-5. The products differ in their duration of action. Mod GRF has an approximately-ideal short duration of action allowing pulsatile dosing, whereas CJC-1-2'9-5 has an extended duration of action which prevents such dosing.
It's important to avoid confusing CJC-1-2'9-5 with "CJC-1-2'9-5 w/o DAC." The latter is not CJC-1-2'9-5, but rather is misnamed Mod GRF. When a peptide doesn't have DAC, it's not CJC-1-2'9-5.
CJC 1-2'9-5 is sometimes marketed as "CJC-1-2'9-5 with DAC." This simply is CJC-1-2'9-5.




2. When to use CJC-1-2'9-5

This product is most suited to instances where an individual wishes to inject infrequently and is seeking substantive support for GH production rather than a maximum or near-maximum increase. This is because the flat blood levels it provides do not match up well with pulsatile dosing, which is needed for greatest effect. The steady levels can provide very good support for natural GH pulses, however.
Relatively rarely, adverse side effects associated with excessive GH use, such as pain from nerve compression (such as carpal tunnel pain), excessive water retention, or reduced in-su-lin sensitivity can occur from CJC-1-2'9-5 usar. The cause is stimulation of a greater amount of GH production than is suitable for the individual case. The solution is to discontinue use until the problem is resolved, and to reduce dosage when resuming use.
For ongoing support of GH production, at doses recommended below, CJC-1-2'9-5 does not need to be cycled.




3. How to use CJC-1-2'9-5


CJC 1-2'9-5 is typically provided in vials containing 2 or 5 mg of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.
At time of dosing, an in-su-lin syringe is used to draw and then inject the desired amount. In the above example, a 1000 mcg dose would require a volume of 1 mL, or "100 IU" as marked on an in-su-lin syringe.
Injection may be subcutaneous, intramuscular, or intravenous according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe, if there is room. This reduces the total number of injections required.
When recommending CJC 1-2'9-5, I ordinarily recommend a dosage of 1000 mcg at a time, twice per week.